THERE have been reports of the inctubation of human peripheral blood lymphocytes from cancer patients with basic protein of myelin in the presence of guinea-pig macrophages, in order to diagnose malignant disease in humans. Different techniques have been tried in order to identify sensitized lymphocytes. This can be done either indirectly, by detection of released lymphokines as in the MEM test established by Field and Caspary (1970) and improved by Porzsolt, Tautz and Ax (1975) or directly, by making visible the interaction of lymphocytes with basic protein as was done by Sabolovic et al. (1975) . These methods identify sensitized human blood lymphocytes by changes on their cell suirfaces. The alteration of the lymphocyte surface presupposes a special interaction with basic proteins, which couild be shown by the reduced electrophoretic mobility of sensitized blood lymphocytes and by simple histone F2al micro-agglutination (Sabolovic et al., 1975) .
The aim of our investigation was to simplify and standardize these agglutination techniques by using defined synthetic peptides, in particular poly-Llysine 3400 (PAL test), to detect sensitized lymphocytes in patients with malignant diseases.
MATERIALS AND AIETHODS
Lymphocytes from 5 ml of heparinized blood were isolated by a single-step discontinuous Ficoll-Isopaque(R) gradient, as described by English and Anderson (1974) . Synthetic peptides were purchased from Miles, D-4000 Frankfurt and Sigma, D-8000 Miinchen. The lymphocytes wNere washed and diluted with Hanks' solution (Flowvi Laboratories) to a concentration of 6 x 106/ml. The lymphocyte suspension must be as pure as possible. Non-lymphoid cells and erythrocytes will disturb the test through non-specific agglutination. Basic polypeptide fractions were dissolved in 0-145 M NaCl, pH 7 0, at a concentration of 0 05 mg/ml.
Equal volumes of lymphocyte suspension and peptide solution were mixed; for example, 1 ml of 6 x 106/ml lymphocytes and 1 ml of 0-05mg/ml basic peptide. Peptide solubility in physiological media and a structural similarity to histone F2al were the preconditions for the selection of the peptides used. Histone F2al is a component of basic nuclear protein, consisting mainly of arginine, Poly-D-Lysine lysine and glycine with a molecular weight of 13,500 (Wilhelm, Spelsberg and Hnilica, 1971) .
The most evident differences in the reaction ofhumanperipheral bloodlymphocytes between healthy donors and malignant donors occurred in the presence of PLL with a molecular weight of 3400. Lymphocytes from patients with malignant tumours were agglutinated in contrast to lymphocytes from healthy subjects at concentrations of 0-1 mg/ml and 0-05 mg/ml. D-Lysine, L-lysine, gly-L-lys and Lleucyl-glycyl-glycine reacted neither with lymphocytes of healthy subjects nor with lymphocytes of patients with a malignancy. The other peptides listed above lead to an agglutination by control persons as well as by patients suffering from malig- nant processes. The concentrations used were 1, 0-5, 0-1 and 0-05 mg peptide/ml of 0-145 M NaCl, pH 7-0 (Table I) .
The reaction is independent of the pH within the physiological range 6-5-8-0 (Table II) . (Johns et al., 1973) . These results indicate that a structural relationship necessary for immunological cross-reaction between EF, histone F2al and some antigenic determinants of tumour antigens may exist.
With histone F2al it is indeed possible to recognize sensitized lymphocytes by agglutination (Sabolovic et al., 1975) . It has been shown that PLL with a mol. wt of 3400 has the ability to react in the same wav as histone F2ai. The reason for this phenomenon may be that the nuclear basic protein histone F2al consists of about 1000 lysine beside several other aminoacids (WVilhelm et al., 1971) . Sabolovic et al. (1975) (Kedar et al., 1974) Sabolovic, Sabolovic anld Dumont, 1972) .
In 1975 Plagne et al. reported the appearance of additional slowly migrating peripheral lymphocytes in malignant disease; their function could not be explained. Perhaps these less negative subpopulations of additionally recruited T lymphocytes are the cells which could be detected by the PLL-induced agglutination test (PAL test). We suggest as an explanation that the binding capacity of PLL with mol. wt of 3400 is strong enough to bring these less negatively charged cells into contact with each other, thus leading to agglutination. Intense repulsion forces of more strongly negatively charged lymphocytes, such as from healthy persons, can be overcome only with larger molecules of the higher-mol. wt PLL. The agglutination is not, however, a phenomenon dependent on charge. The peptide-lymphocyte interaction was not influenced by the pH of the reaction medium.
A lot of research is needed to find out about the reaction mechanism and the reason for the interaction of lymphocytes with basic peptides, especially with PLL 3400. The molecule of PLL 3400 possibly represents a synthetic structure "crossreacting" in part with "some tumourspecific or tumour-associated antigens", which were suggested by Johns et al. (1973) in connection with the "encephalithogenic antigen", and histone F2al.
At present the most important thing to be done is to corroborate the microagglutination induced by PLL 3400 and malignant growth by screening a large population of patients.
